Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study.

Clin Ophthalmol · 2021 · PMC8434835 · PMID 34522081

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

15 The lack of significant improvement in BCVA among the treatment-naive eyes was intriguing to note in our investigation, despite a positive trend toward visual gains.

also in 11,005 other papers

a definite trendno p-value reported

Our real-world study demonstrates a definite trend towards an improvement amongst all SD-OCT biomarkers after brolucizumab.

also in 427 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.